Clinical Trial Update: WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on WJMSCs anti-inflammatory therapy for acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• WJMSCs anti-inflammatory therapy

Snippet

Sponsor: Navy General Hospital, Beijing | Conditions: Acute Myocardial Infarction | Phase 2 | Status: UNKNOWN